Armetheon Announces Asian commercialization agreement
CATEGORIES News Events Publications ARCHIVE Armetheon Announces Asian commercialization agreement Armetheon and Lee’s Pharma Enter into Agreement to Develop and […]
News
News
Events, News
Improve Your Deal Outcome by joining Locust Walk Institute in Boston for a Two-Day Course on Deal Preparation and Execution, October 20th and 21st
CATEGORIES News Events Publications ARCHIVE Improve Your Deal Outcome by joining Locust Walk Institute in Boston for a Two-Day Course
Events, News, Publications
Jay Mohr to moderate MassBio’s September 22nd Panel “Term Sheet to Contract Negotiations: Deal or no Deal?”
CATEGORIES News Events Publications ARCHIVE Jay Mohr to moderate MassBio’s September 22nd Panel “Term Sheet to Contract Negotiations: Deal or
News
CORTENDO ADDS TWO LATE-STAGE ASSETS TO ITS RARE ENDOCRINE DISEASE FRANCHISE AND ANNOUNCES RELATED $33.2 MILLION FINANCING
CATEGORIES News Events Publications ARCHIVE CORTENDO ADDS TWO LATE-STAGE ASSETS TO ITS RARE ENDOCRINE DISEASE FRANCHISE AND ANNOUNCES RELATED $33.2
News
And that’s a wrap! Allicense 2015
CATEGORIES News Events Publications ARCHIVE And that’s a wrap! Allicense 2015 From licensing to financing to venture trends, deal-making and
News
DARA BioSciences Announces the Acquisition of Exclusive North American Rights to Oravig® (Miconazole Buccal Tablets 50mg), From Onxeo S.A.
CATEGORIES News Events Publications ARCHIVE DARA BioSciences Announces the Acquisition of Exclusive North American Rights to Oravig® (Miconazole Buccal Tablets
News
Armetheon Closes $24 Million Series B Financing
CATEGORIES News Events Publications ARCHIVE Armetheon Closes $24 Million Series B Financing Dr. Larry Hsu Elected to Board of Directors
News
Cortendo AB Raises up to $27.5M in Additional Private Placement with Leading U.S. and EU Healthcare Investors
CATEGORIES News Events Publications CATEGORIES Cortendo AB Raises up to $27.5M in Additional Private Placement with Leading U.S. and EU
News
Strategic Science & Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S. Commercial Rights to Topical Ibuprofen
CATEGORIES News Events Publications ARCHIVE Strategic Science & Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S.
News
TesoRx and Aspen Group Conclude Investment and Licensing Agreement
CATEGORIES News Events Publications ARCHIVE TesoRx and Aspen Group Conclude Investment and Licensing Agreement (Menlo Park, CA, United States and